Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLNK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM132A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF13A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR4640 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC283045 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
AGAP2-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MASP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEACAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OVAAL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on